Apple (AAPL)
(Delayed Data from NSDQ)
$230.54 USD
+2.97 (1.31%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $230.48 -0.06 (-0.03%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth C Momentum D VGM
Price, Consensus and EPS Surprise
(%)
Will be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for
Should You Add These 3 Top-Performing Mutual Funds to Your Portfolio?
3 Great Mutual Fund Picks for Your Retirement
: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are these 3 Top-Ranked Mutual Funds In Your Retirement Portfolio?
5 Top ETFs of Last Week
FAT Brands (FAT) Soars 9.1%: Is Further Upside Left in the Stock?
Other News for
Heron Therapeutics Announces the Inclusion of ZYNRELEF® as a Qualifying Product Under the Proposed 2025 Non-Opioid Policy for Pain Relief Under the OPPS and the ASC Payment System
Farnborough Airshow: Boeing Adapts Presence to Prioritize Factory Safety and Quality
LENZ Therapeutics Announces $30 Million Investment from Ridgeback Capital
Integra LifeSciences to Host Second Quarter 2024 Financial Results Conference Call on July 29, 2024
Stryker Completes Acquisition of Artelon, Inc.